References
- 1. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003 May 14; 289(18): 2363-9.
- 2. Wolf-Maier K, Cooper R, Kramer H, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension. 2004;43:10-17.
- 3. 2013 ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal doi:10.1093/ eurheartj/eht151 published June 14, 2013.
- 4. Bramlage P, Böhm M, Volpe M, Khan BV, Paar DW, Tebbe U and Thoenes M. A Global Perspective on Blood Pressure Treatment and Control in a Referred Cohort of Hypertensive Patients. J Clin Hypertens 2010. 12(9): 666-677.
- 5. Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension. 2010;55(2):399-407.
- 6. Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich). 2002;4(6):393-404.
- 7. Jamerson K, Weber MA, Bakris GL, DahlofB, Pitt B, ShiV, HesterA, Gupte J, Gatlin M, Velazquez EJ. Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients. 2008. N engl J med 359; 23.
- 8. Waeber B. Treatment strategy to control blood pressure optimally in hypertensive patients. Blood Press. 2001;10:62-73.
- 9. Ruzicka M, Leenen FH. Monotherapy versus combination therapy as first line treatment of uncomplicated arterial hypertension. Drugs. 2001;61:943-954.
- 10. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289:2560-2572.
- 11. Epstein M, Bakris G. Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy. Arch Intern Med. 1996;156:1969-1978.
- 12. Gradman AH, Basile JN, Carter BL, Bakris GL; American Society of Hypertension Writing Group. Combination therapy in hypertension. J Clin Hypertens (Greenwich). 2011;13:146-154.
- 13. Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med. 2009;122:290-300.
- 14. Bangalore S, Kamalakkannan G, Parkar S, at al. Fixed- Dose Combinations Improve Medication Compliance: meta-analysis on 11,925 participants from 9 trials, Am J Med (2007) 120, 713-719.
- 15. Calhoun DA, Lacourciere Y, Chiang YT, Glazer RD. Triple antihypertensive therapy with Amlodipine, Valsartan, and Hydrochlorothiazide. A randomized clinical trial. Hypertension. 2009;54(1):32-39.
- 16. Oparil S, Melino M, Lee J, Fernandez V, Heyrman R. Triple therapy with Olmesartan medoxomil, Amlodipine besylate, and Hydrochlorothiazide in adult patients with hypertension: the TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study. Clin Ther. 2010;32(7):1252-69.
- 17. Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial- Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366 (9489):895-906.
- 18. Jadhav U, Hiremath J,, Namjoshi DJ, Gujral VK, Tripathi KK, Siraj M, Shamanna P, Safar8 M. Blood Pressure Control with a Single-Pill Combination of Indapamide Sustained- Release and Amlodipine in Patients with Hypertension: The EFFICIENT Study. PLos one. 2014. 9(4): e92955.
- 19. Kalman T. Antihypertensive Efficacy of Triple Combination Perindopril/ Indapamide Plus Amlodipine in High-Risk Hypertensives: Results of the PIANIST Study (Perindopril-Indapamide plus Amlodipine in high risk hypertensive patients): original research article. Am J Cardiovasc Drugs. 2014.